Clinical Trial Update: Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial evaluating symptomatic treatment for chronic idiopathic urticaria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Snippet

Sponsor: Faes Farma, S.A. | Conditions: Urticaria | Phase 3 | Status: COMPLETED